1110 — Kingworld Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Kingworld Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	261	198	256	194	250
Net Total Accounts Receivable
Net Total Receivables	297	280	237	235	203
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	715	640	624	589	608
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	168	210	300	386	424
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	1,255	1,214	1,263	1,338	1,416
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	556	474	542	464	515
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	664	597	648	719	776
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	592	617	616	619	640
Total Liabilities & Shareholders' Equity	1,255	1,214	1,263	1,338	1,416
Total Common Shares Outstanding